Verapamil Clinical Trials Verapamil RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
Condition:   Type1 Diabetes Interventions:   Device: HCL;   Drug: verapamil 120mg tablet;   Device: non-HCL;   Drug: placebo Sponsors:   Jaeb Center for Health Research;   University of Minnesota;   Medtronic;   Tandem Diabetes Care, Inc.;   DexCom, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2020 Category: Research Source Type: clinical trials

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
Condition:   Type1 Diabetes Interventions:   Combination Product: HCL and placebo;   Combination Product: HCL and verapamil;   Combination Product: non-HCL and verapamil;   Combination Product: non-HCL and placebo Sponsors:   Jaeb Center for Health Research;   University of Minnesota;   Medtronic;   Tandem Diabetes Care, Inc.;   DexCom, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2020 Category: Research Source Type: clinical trials

Adenosine Versus Verapamil for Management of Supraventricular Tachycardia Post- Coronary Artery Bypass Grafting
Condition:   Supraventricular Tachycardia Interventions:   Drug: adenosine;   Drug: verapamil Sponsor:   Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2019 Category: Research Source Type: clinical trials